Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants aged 18 to 65 years old; 2. Right-handed; 3. Evaluated by at least one professional psychiatrist with associate director or above in psychiatry and diagnosed with schizophrenia (SZ) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); 4. Having a stable antipsychotic medication regimen for more than 2 weeks prior to the start of the study and throughout the entire study period; 5. Capable of understanding and completing the tests required for the study; 6. Patients and/or guardians provide informed consent.
Exclusion criteria
Exclusion criteria: 1. Presence of severe systemic diseases, including but not limited to serious liver, kidney, respiratory, cardiovascular, endocrine diseases, hematologic disorders, or neoplastic diseases; 2. Diagnosed with other primary psychiatric disorders according to DSM-V; 3. Skin lesions or dermatological conditions at the electrode site; 4. Use of metal implants or any electro-sensitive support devices; 5. Significant neurological disorders that may affect cognition or treatment response (e.g., stroke, epilepsy); 6. Pregnancy or lactation; 7. Undergoing repetitive transcranial magnetic stimulation (rTMS) or other neuromodulatory treatments; 8. Participation in another clinical trial concurrently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pattern Recognition Memory, PRM;Stocking of Cambridge, SOC;Spatial Working Memory, SWM;Rapid Visual Information Processing, RVP; | — |
Secondary
| Measure | Time frame |
|---|---|
| The positive and negative syndrome scale, PANSS; | — |
Countries
China
Contacts
Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University